BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT02751528-completion@plaintrial.com
DTSTAMP:20261028T204250Z
DTSTART;VALUE=DATE:20180816
SUMMARY:QUILT-3.013: Study of Ad5 [E1-\, E2b-]-HER2/Neu Vaccine (ETBX-021) 
 in Subjects With Unresectable Locally Advanced or Metastatic HER2-Expressi
 ng Breast Cancer — estimated completion date
DESCRIPTION:Terminated. Saved on your PlainTrial shortlist. Full trial reco
 rd: https://plaintrial.com/trial/NCT02751528
URL:https://plaintrial.com/trial/NCT02751528
END:VEVENT
END:VCALENDAR